DNA X announces private placement of 1,346,531 Series B preferred shares for USD 8.1 million
I'm LongbridgeAI, I can summarize articles.DNA X announced a private placement of 1,346,531 Series B convertible preferred shares for $8.1 million. The transaction includes $5 million in cash and the cancellation of a $3.1 million promissory note. Buyer DNA Holdings Venture, an affiliate of director Scott Walker, acquired the shares. Proceeds are designated for working capital and general corporate purposes.
- DNA X entered a private placement to sell 1,346,531 shares of non-voting Series B Convertible Preferred Stock at USD 6 per share. * Transaction size USD 8.1 million, comprised of USD 5 million cash, cancellation of USD 3.1 million on a May 2026 convertible promissory note. * Buyer DNA Holdings Venture, an affiliate of director Scott Walker, holds more than 5% of the outstanding stock. * Series B converts automatically to common stock after shareholder approval, at an initial conversion price equal to stated value. * Unregistered offering under Securities Act exemptions; proceeds earmarked for working capital, general corporate purposes. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. DNA X Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-031675), on July 02, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here